GALECTO, INC.

Profile

Company Names

GALECTO, INC.
GALECTO INC.

Addresses

75 STATE STREET, SUITE 100, BOSTON, MA 02109

GALECTO BIOTECH AB, OLE MAALOES VEJ3, COPENHAGEN, G7 DK-2200

OLE MAALOES VEJ3, COPENHAGEN, G7 DK-2200

Phone Numbers

(+45) 70 70 52 10
45-70-70-52-10
45-4132-3698

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$428,342,902.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-11-12 
$285,000,000.00 
$285,000,000.00 
$0.00 
Equity 
2
2020-09-25 
$64,199,679.00 
$64,199,679.00 
$0.00 
Equity 
1
2019-12-31 
$79,143,223.00 
$123,718,248.00 
$44,575,025.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JULIANNE 
 
BRUNO 
DIRECTOR
GALECTO, INC.
CHRISTOPHER 
 
CAIN 
DIRECTOR
GALECTO, INC.
EREZ 
 
CHIMOVITS 
DIRECTOR
ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP   |  ADICET BIO, INC.   |  LOGICBIO THERAPEUTICS, INC.   |  ATOX BIO INC.   |  NOVUS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  IMMPACT BIO USA INC.   |  GALECTO, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.
STEPHAN 
 
CHRISTGAU 
DIRECTOR
GALECTO, INC.
JAYSON 
 
DALLAS 
DIRECTOR
RIVUS PHARMACEUTICALS, INC.   |  GALECTO, INC.   |  FAETH THERAPEUTICS, INC.
LORI 
 
FIRMANI 
EXECUTIVE OFFICER
GALECTO, INC.
JON 
 
FREVE 
EXECUTIVE OFFICER
GALECTO, INC.
CARL 
 
GOLDFISCHER 
DIRECTOR
BRAINCELLS INC   |  ENTEROMEDICS INC   |  METABOLEX, INC.   |  PTC THERAPEUTICS, INC.   |  PHARMAKEA, INC.   |  SYNGEN INC.   |  SIDECAR THERAPEUTICS, INC.   |  IMARA INC.   |  GALECTO, INC.
JAKOB 
DYNNES 
HANSEN 
EXECUTIVE OFFICER
GALECTO INC.
PETER 
 
HARWIN 
DIRECTOR
FAIRMOUNT HEALTHCARE FEEDER FUND LTD.   |  FAIRMOUNT HEALTHCARE FUND L.P.   |  QUELLIS BIOSCIENCES, INC.   |  VIRIDIAN, LLC   |  FAIRMOUNT HEALTHCARE FEEDER FUND II LTD.   |  FAIRMOUNT HEALTHCARE FUND II L.P.   |  VIRIDIAN THERAPEUTICS, INC.   |  UNUM THERAPEUTICS INC.   |  PARAGON THERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE CO-INVEST L.P.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE FEEDER FUND II L.P.   |  FAIRMOUNT HEALTHCARE CO-INVEST II L.P.   |  SPYRE THERAPEUTICS, INC.   |  GALECTO, INC.
CHAO 
Q. 
KHUONG 
DIRECTOR
GALECTO, INC.
SOREN 
 
LEMONIUS 
DIRECTOR
GALECTO, INC.
CHANDRA 
 
LEO 
DIRECTOR
GYNESONICS, INC   |  GALECTO, INC.   |  LONGBOARD PHARMACEUTICALS, INC.   |  DREN BIO, INC.   |  FORE US BIO INC.
SOREN 
 
MOLLER 
DIRECTOR
GALECTO, INC.
AMIT 
 
MUNSHI 
DIRECTOR
CYNVENIO BIOSYSTEMS INC   |  OXEIA BIOPHARMACEUTICALS, INC.   |  CYTRELLIS BIOSYSTEMS, INC.   |  PULMATRIX, INC.   |  ONEBIOPHARMA INC.   |  GALECTO, INC.   |  ZURA BIO LTD
HANS 
 
SCHAMBYE 
EXECUTIVE OFFICER, DIRECTOR
GALECTO INC.   |  GALECTO, INC.
HANS 
T. 
SCHAMBYE 
EXECUTIVE OFFICER, DIRECTOR
GALECTO, INC.
DAVID 
 
SHAPIRO 
DIRECTOR
ALTAIR THERAPEUTICS, INC.   |  WELLPARTNER INC   |  INTERCEPT PHARMACEUTICALS INC   |  KPS SPECIAL SITUATIONS FUND IV, LP   |  KPS SPECIAL SITUATIONS FUND IV (A), LP   |  KPS SPECIAL SITUATIONS FUND IV (B), LP   |  SCOUT SECURITY, INC.   |  VANSHAP CAPITAL VALUE FUND, LP   |  PROPEL MEDIA, INC.   |  FIRST LIGHT BIOSCIENCES INC.   |  ARCTURUS THERAPEUTICS LTD.   |  GALECTO, INC.   |  VANSHAP CAPITAL FOOD TECHNOLOGY FUND I, LP   |  SCOUT SECURITY LTD   |  OPEN UNICORN SPV SPACEX 1, LP   |  OPEN UNICORN FUND, LP   |  AV APEX FUND, LP   |  AV APEX FUND-A, LP   |  KPS SPECIAL SITUATIONS FUND VI (EXECUTIVE), LP   |  KPS AS CO-INVEST, LP   |  OPEN SPX II, LP   |  OPEN OAI I, LP
KAREN 
 
WAGNER 
DIRECTOR
KALA PHARMACEUTICALS, INC.   |  GALECTO, INC.
GARRETT 
 
WINSLOW 
EXECUTIVE OFFICER
GALECTO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-11-12 
2020-11-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-09-25 
2020-01-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES LLC
2347
NONE
NONE
LEERINK PARTNERS LLC
39011
NONE
NONE
UBS SECURITIES LLC
7654
NONE
NONE
LIFESCI CAPITAL, LLC
168404